Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian P Selinger

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Alimentary Pharmacology & Therapeutics|August 8, 2022
Editorial: progress towards more comprehensively understanding the sources of corticosteroids for patients with inflammatory bowel disease-authors' replyKonstantina Rosiou, Christian P Selinger
Alimentary Pharmacology & Therapeutics|April 15, 2020
Letter: pregnant women with IBD are more likely to be adherent to biologic therapies than other medicationsRobyn Laube, Christian P Selinger
Expert Review of Pharmacoeconomics & Outcomes Research|August 21, 2014
The cost-effectiveness of infliximab in Crohn's diseaseClaire Smart, Christian P Selinger
Alimentary Pharmacology & Therapeutics|March 18, 2026
Editorial: Optimal Treatment for Older Patients With Inflammatory Bowel Disease: How to Detect and Manage Frailty?Isabel Carbery, Christian P Selinger
Alimentary Pharmacology & Therapeutics|April 21, 2021
Editorial: standardising inclusion and outcome criteria for pouchitis-a fragile consensus perhaps but a first step in the right directionRobyn Laube, Christian P Selinger
Alimentary Pharmacology & Therapeutics|August 28, 2020
Letter: recognising frailty in patients with inflammatory bowel disease is crucial for appropriate personalised treatmentJessica Lovatt, Christian P Selinger
Digestive Diseases and Sciences|May 2, 2022
Using the PIDA on Your PDA: Providing Personalized Education and Decision Support for Women with IBD of Childbearing AgeKonstantina Rosiou, Christian P Selinger
Alimentary Pharmacology & Therapeutics|April 26, 2022
Editorial: choosing the optimal screening method for latent TB in patients with IBD commencing anti-TNF therapyJessica Lovatt, Christian P Selinger
Current Medical Research and Opinion|July 23, 2020
Re: Roberti R, Iannone LF, Palleria C, et al. Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy. Curr Med Res Opin. 2020. DOI:10.1080/03007995.2020.1786681Robyn Laube, Christian P Selinger
Digestion|April 9, 2008
Gastric antral vascular ectasia (GAVE): an update on clinical presentation, pathophysiology and treatmentChristian P Selinger, Yeng S Ang
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Alimentary Pharmacology & Therapeutics|August 8, 2022
Editorial: progress towards more comprehensively understanding the sources of corticosteroids for patients with inflammatory bowel disease-authors' replyKonstantina Rosiou, Christian P Selinger
Alimentary Pharmacology & Therapeutics|April 15, 2020
Letter: pregnant women with IBD are more likely to be adherent to biologic therapies than other medicationsRobyn Laube, Christian P Selinger
Expert Review of Pharmacoeconomics & Outcomes Research|August 21, 2014
The cost-effectiveness of infliximab in Crohn's diseaseClaire Smart, Christian P Selinger
Alimentary Pharmacology & Therapeutics|March 18, 2026
Editorial: Optimal Treatment for Older Patients With Inflammatory Bowel Disease: How to Detect and Manage Frailty?Isabel Carbery, Christian P Selinger
Alimentary Pharmacology & Therapeutics|April 21, 2021
Editorial: standardising inclusion and outcome criteria for pouchitis-a fragile consensus perhaps but a first step in the right directionRobyn Laube, Christian P Selinger
Alimentary Pharmacology & Therapeutics|August 28, 2020
Letter: recognising frailty in patients with inflammatory bowel disease is crucial for appropriate personalised treatmentJessica Lovatt, Christian P Selinger
Digestive Diseases and Sciences|May 2, 2022
Using the PIDA on Your PDA: Providing Personalized Education and Decision Support for Women with IBD of Childbearing AgeKonstantina Rosiou, Christian P Selinger
Alimentary Pharmacology & Therapeutics|April 26, 2022
Editorial: choosing the optimal screening method for latent TB in patients with IBD commencing anti-TNF therapyJessica Lovatt, Christian P Selinger
Current Medical Research and Opinion|July 23, 2020
Re: Roberti R, Iannone LF, Palleria C, et al. Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy. Curr Med Res Opin. 2020. DOI:10.1080/03007995.2020.1786681Robyn Laube, Christian P Selinger
Digestion|April 9, 2008
Gastric antral vascular ectasia (GAVE): an update on clinical presentation, pathophysiology and treatmentChristian P Selinger, Yeng S Ang
Pageof 12